Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Talking generics in the UK with Mylan’s Jean-Yves Brault

Following the recent UK launch by Mylan of Brabio, the first generic version of Teva’s Copaxone for multiple sclerosis, we spoke to Mylan’s UK Country Manager Jean-Yves Brault about the drug, as well as the current opportunities and challenges in the UK’s generics market.

Free download worth over $5000
Download our 2018 Technology, Media and Telecoms Predictions Report

Worth up to $5,850

In this report, we look at the 30 big tech themes identifying winners and losers for each theme. This report will impact all industries helping:

  • CEOs/Senior Staff: in all industries understand the disruptive threats to their competitive landscape
  • Investors: Helps fund managers focus their time on the most interesting investment opportunities in global technology, media and telecoms

Go Top